Xinyi Liu

ORCID: 0000-0003-3609-8479
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Systemic Lupus Erythematosus Research
  • Galectins and Cancer Biology
  • Blood Coagulation and Thrombosis Mechanisms
  • Cytokine Signaling Pathways and Interactions
  • Oral health in cancer treatment
  • Reproductive Biology and Fertility
  • Mobile Health and mHealth Applications
  • Oral Health Pathology and Treatment
  • Ovarian function and disorders
  • Head and Neck Cancer Studies
  • Diabetes Management and Education
  • Peptidase Inhibition and Analysis
  • Digital Mental Health Interventions
  • Rheumatoid Arthritis Research and Therapies

First Affiliated Hospital of Xi'an Jiaotong University
2025

Zhengzhou University
2020

In vitro fertilization-embryo transfer (IVF-ET) stands as one of the most prevalent treatments for infertility. During an IVF-ET cycle, time interval between trigger shot and oocyte pickup (OPU) is a pivotal period follicular maturation, which determines mature oocytes yields impacts success subsequent procedures. However, accurately predicting this severely hindered by variability clinicians'experience that often leads to suboptimal retrieval rate. To address challenge, we propose ILETIA,...

10.48550/arxiv.2501.16386 preprint EN arXiv (Cornell University) 2025-01-25

Cell death contributes to the pathogenesis of rheumatoid arthritis (RA) through various pathways. Disulfidptosis is a recently discovered novel form cell characterized by abnormal accumulation intracellular disulfide bonds. It remains unclear for association between RA and disulfidptosis. A comprehensive analysis three GEO datasets was presented in this study. First, involved use weighted gene co-expression network (WGCNA) differential were employed identify key module genes related...

10.2147/jir.s505746 article EN cc-by-nc Journal of Inflammation Research 2025-03-01

To assess the clinical efficacy of 5-aminolaevulinic acid photodynamic therapy (5-ALA-PDT) in treating oral potentially malignant disorders (OPMDs) and investigate utility toluidine blue staining autofluorescence examination for monitoring 5-ALA-PDT. A prospective cohort study was conducted, including 75 OPMDs patients who underwent 5-ALA-PDT follow-up observation. The patients' lesion size presentation were recorded to evaluate Toluidine performed as auxiliary methods, aiming their...

10.3290/j.cjdr.b6097614 article EN PubMed 2025-03-31

Objective: To investigate the expression levels of programmed death protein 1 (PD-1)、T cell immunoglobulin domain and mucin 3(TIM-3)、lymphocyte activating gene 3 (LAG-3) B T lymphocyte attenuator (BTLA) in Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) their effects on prognosis. Methods: The paraffin specimens 30 patients with DLBCL, NOS newly diagnosed People's Hospital Zhengzhou University were stained immunohistochemistry. single positive co-expression above...

10.3760/cma.j.cn112137-20200107-00045 article EN PubMed 2020-09-29

<sec> <title>BACKGROUND</title> The number of people with diabetes is on the rise globally. Self-management and health education patients are keys to control diabetes. With development digital therapies artificial intelligence, chatbots have potential provide health-related information improve accessibility effectiveness in field patient self-management. </sec> <title>OBJECTIVE</title> This study systematically reviews current research status self-management support chatbots....

10.2196/preprints.60380 preprint EN 2024-05-09

Objective: To compare the efficacy and safety of pro-urokinase reteplase in treatment patients with acute ST elevation myocardial infarction (STEMI). Methods: STEMI patients, who received intravenous thrombolytic therapy Henan registry between September 2016 August 2018, were eligible for this study. A total 5479 from 66 hospitals screened divided into group (n=638) (n=702) according to drugs. Data including patient demographics, risk factors, medical histories, information at admission,...

10.3760/cma.j.cn112148-20201103-00877 article EN Chinese journal of cardiovascular diseases 2021-09-24
Coming Soon ...